Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
CrowdStrike pulled back 4% on the week to $212.92, and for the first time in months the Street's freshly raised price targets are actually above where the stock trades — a setup that flips the tension heading into the August 25 earnings print.
The analyst activity this week has been remarkable in scale and consistency. Every firm that acted raised its target, with no downgrades and no cuts to ratings. Mizuho lifted to $240, Truist to $245, Barclays to $235, and TD Cowen to $235 — all within the past 48 hours. RBC Capital went to $256 earlier in the week. These moves are large: Barclays jumped from $169, TD Cowen from $175, Mizuho from $175. The consensus mean now sits around $206, but the cluster of individual targets in the $230-$256 range suggests the real Street view is running well ahead of that blended number. One data point to flag: Cantor Fitzgerald reported a target cut from $725 to $250 — a move so large it almost certainly reflects a prior stale or misrecorded figure rather than a genuine bear turn, and the Overweight rating was maintained. The direction of travel from the Street is unambiguous: bullish, and accelerating into the print.
Short positioning tells a calmer story but contains a subtle shift. SI nudged up fractionally on the day to 10.49% of float — a small reversal after a 4% weekly decline that had been the dominant trend since mid-July. That weekly drop confirms the short-unwind story first flagged two weeks ago remains broadly intact, though the daily tick upward bears watching. The borrow market gives shorts no reason to hurry. Availability is effectively unlimited, with over 949 million shares available to lend, and cost to borrow has eased back to 0.32% — near the low end of its range all year. Options positioning has tightened slightly relative to recent history: the put/call ratio at 0.961 is running about 1.6 standard deviations above its 20-day mean of 0.948. That is a mild uptick in defensiveness, consistent with earnings-proximity hedging rather than outright fear.
CEO George Kurtz sold approximately $2.15 million worth of shares on August 17 across multiple tranches — a continuation of a pattern that has now produced nearly $9.7 million in net insider sales over the past 90 days. The significance score on each trade is low, suggesting this is plan-based selling rather than a discretionary call, but the cadence of selling directly into a pre-earnings rally will remain a talking point. On the institutional side, FMR added over 16.8 million shares in its latest reported period and JP Morgan Asset Management added 14.2 million — both material additions that underpin the bullish institutional flow picture even as the CEO lightens up.
The June 3 earnings print is the most instructive recent data point for context. The stock fell 6.5% the next day and 15.8% over the following five days — a severe reaction that reflected not just the headline but lingering customer trust concerns from the 2025 outage. The prior print in June was essentially flat on day one. That asymmetry — a big miss punishes sharply, a beat produces minimal relief — is the key risk framing heading into August 25. Valuation provides little cushion: PE runs near 150x and EV/EBITDA near 105x, both easing modestly on the week but still stretched. The factor score for 12-month forward EPS trajectory sits at the 83rd percentile, suggesting the growth case remains intact in the estimate base. Whether the print validates that or reopens the June wounds is the only question that matters on August 25.
See the live data behind this article on ORTEX.
Open CRWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
